D1 and D4 dopaminergic receptor interplay mediates coincident G protein-independent and dependent regulation of glutamate NMDA receptors in the lateral amygdala

Journal of Neurochemistry

Volumn 106, Issue 6, 2008, Pages 2421-2435

  Martina, Marzia ^a   Bergeron, Richard ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Brain slices; Dopamine; NMDA receptor; Protein protein interaction; Synaptic transmission; Whole cell recording

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RACLOPRIDE; SULPIRIDE; VANOXERINE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT;

AMYGDALA; ANIMALS; DOPAMINE; GLUTAMIC ACID; MEMBRANE POTENTIALS; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D4; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

RATTUS;

EID: 50849140790     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05584.x     Document Type: Article

References (59)

1. Andersen P. H. (1989) The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166, 493 504.
2. Beazely M. A., Tong A., Wei W. L., Van Tol H., Sidhu B. MacDonald J. F. (2006) D2-class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet-derived growth factor receptor-dependent. J. Neurochem. 98, 1657 1663.
3. Bergson C., Mrzljak L., Smiley J. F., Pappy M., Levenson R. Goldman-Rakic P. S. (1995) Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J. Neurosci. 15, 7821 7836.
4. Blair H. T., Schafe G. E., Bauer E. P., Rodrigues S. M. LeDoux J. E. (2001) Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn. Mem. 8, 229 242.
5. Brinley-Reed M. McDonald A. J. (1999) Evidence that dopaminergic axons provide a dense innervation of specific neuronal subpopulations in the rat basolateral amygdala. Brain Res. 850, 127 135.
6. Cepeda C. Levine M. S. (1998) Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum. Dev. Neurosci. 20, 1 18.
7. Cepeda C. Levine M. S. (2006) Where do you think you are going? The NMDA-D1 receptor trap. Sci. STKE 2006, pe20.
8. Cepeda C., Colwell C. S., Itri J. N., Chandler S. H. Levine M. S. (1998) Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. J. Neurophysiol. 79, 82 94.
9. Chen G., Greengard P. Yan Z. (2004a) Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex. Proc. Natl Acad Sci. USA 101, 2596 2600.
10. Chen X., Zhang L. Kombian S. B. (2004b) Dopamine-induced synaptic depression in the parabrachial nucleus is independent of CTX- and PTX-sensitive G-proteins, PKA and PLC signalling pathways. Brain Res. 995, 236 246.
11. Chergui K. Lacey G. (1999) Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432. Neuropharm. 38, 223 231.
12. Cui C., Xu M. Atzori M. (2006) Voltage-dependent block of N-methyl-D-aspartate receptors by dopamine D1 receptor ligands. Mol. Pharmacol. 70, 1761 1770.
13. Felder C. C., Jose P. A. Axelrod J. (2006) The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J. Pharmacol. Exp. Ther. 38, 171 175.
14. Garris P. A. Wightman R. M. (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14, 442 450.
15. Gean P. W. Chang F. C. (1992) Pharmacological characterization of excitatory synaptic potentials in rat basolateral amygdaloid neurons. Synapse 11, 1 9.
16. Grace A. A. (2002) Dopamine, in Neuropsychopharmacology. The Fifth Generation of Progress. An Official Publication of the American College of Neuropsychopharmacology (Davis K. L., Charney D. Nemeroff C., eds pp. 120 132. Lippincott Williams & Wilkins, Philadelphia.
17. Greengard P. (2001) The neurobiology of slow synaptic transmission. Science 294, 1024 1030.
18. Gurden H., Takita M. Jay T. M. (2000) Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J. Neurosci. 20, RC106.
19. 2+conductance. J. Neurosci. 17, 3334 3342.
20. Hurd Y. L., McGregor A. Ponten M. (1997) In vivo amygdala dopamine levels modulate cocaine self-administration behaviour in the rat: D1 dopamine receptor involvement. Eur. J. Neurosci. 9, 2541 2548.
21. Kotecha S. A., Oak J. N., Jackson M. F., Perez Y., Orser B. A., Van Tol H. H. MacDonald J. F. (2002) A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 35, 1111 1122.
22. LeDoux J. E. (2000) Emotion circuits in the brain. Annu. Rev. Neurosci. 23, 155 184.
23. LeDoux J. E., Cicchetti P., Xagoraris A. Romanski L. M. (1990) The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J. Neurosci. 10, 1062 1069.
24. Lee F. J. Liu F. (2004) Direct interactions between NMDA and D1 receptors: a tale of tails. Biochem. Soc. Trans. 32, 1032 1036.
25. Lee F. J., Xue S., Pei L., Vukusic B., Chery N., Wang Y., Wang Y. T., Niznik H. B., Yu X. M. Liu F. (2002) Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111, 219 230.
26. Leonard S. K., Anderson C. M., Lachowicz J. E., Schulz D. W., Kilts C. D. Mailman R. B. (2003) Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase. Synapse 50, 320 333.
27. Liu X. Y., Chu X. P., Mao L. M. et al. (2006) Modulation of D2R-NR2B Interactions in Response to Cocaine. Neuron 52, 897 909.
28. Maggos C. E., Spangler R., Zhou Y., Schlussman S. D., Ho A. Kreek M. J. (1997) Quantitation of dopamine transporter mRNA in the rat brain: mapping, effects of "binge" cocaine administration and withdrawal. Synapse 26, 55 61.
29. Martina M., Krasteniakov N. V. Bergeron R. (2003) D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons. J. Physiol. 548, 411 423.
30. McDonald A. J. (1992) Projection neurons of the basolateral amygdala: a correlative Golgi and retrograde tract tracing study. Brain Res. Bull. 28, 179 185.
31. McDonald A. J. (1998) Cortical pathways to the mammalian amygdala. Prog. Neurobiol. 55, 257 332.
32. McDonald A. J. Augustine J. R. (1993) Localization of GABA-like immunoreactivity in the monkey amygdala. Neuroscience 52, 281 294.
33. McGaugh J. L. (2000) Memory - a century of consolidation. Science 287, 248 251.
34. Meador-Woodruff J. H., Mansour A., Grandy D. K., Damask S. P., Civelli O. Watson Jr. S. J. (1992) Distribution of D5 dopamine receptor mRNA in rat brain. Neurosci. Lett. 145, 209 212.
35. Meisenzahl E. M., Schmitt G. J., Scheuerecker J. Moller H. J. (2007) The role of dopamine for the pathophysiology of schizophrenia. Int. Rev. Psychiatry 19, 337 345.
36. Missale C., Nash S. R., Robinson S. W., Jaber M. Caron M. G. (1998) Dopamine receptors: from structure to function. Physiol. Rev. 78, 189 225.
37. Munro L. J. Kokkinidis L. (1997) Infusion of quinpirole and muscimol into the ventral tegmental area inhibits fear-potentiated startle: implications for the role of dopamine in fear expression. Brain Res. 746, 231 238.
38. Neve K. A., Seamans J. K. Trantham-Davidson H. (2004) Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24, 165 205.
39. Newman A. H. Kulkarni S. (2002) Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic - A focus on analogues of benztropine and rimcazole. Med. Res. Rev. 22, 429 464.
40. Oak J. N., Oldenhof J. Van Tol H. H. (2000) The dopamine D(4) receptor: one decade of research. Eur. J. Pharmacol. 405, 303 327.
41. Paré D. Smith Y. (1993) Distribution of GABA immunoreactivity in the amygdaloid complex of the cat. Neuroscience 57, 1061 1076.
42. Paré D., Quirk G. J. LeDoux J. E. (2004) New vistas on amygdala networks in conditioned fear. J. Neurophysiol. 92, 1 9.
43. Pickel V. M., Colago E. E., Mania I., Molosh A. I. Rainnie D. G. (2006) Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala. Neuroscience 142, 671 690.
44. Rainnie D. G., Asprodini E. K. Shinnick-Gallagher P. (1991) Excitatory transmission in the basolateral amygdala. J. Neurophysiol. 66, 986 998.
45. Rosenzweig-Lipson S. Barrett J. E. (1995) K-channel blockers attenuate the presynaptic effects of the D2/D3 agonist quinpirole in monkeys. Pharmacol. Biochem. Behav. 51, 843 848.
46. Rothman R. B., Baumann M. H., Prisinzano T. E. Newman A. H. (2008) Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem. Pharmacol. 75, 2 16.
47. Russchen F. T., Bakst I., Amaral D. G. Price J. L. (1985) The amygdalostriatal projections in the monkey. An anterograde tracing study. Brain Res. 329, 241 257.
48. Sah P., Faber E. S., Lopez de Armentia M. Power J. (2003) The amygdaloid complex: anatomy and physiology. Physiol. Rev. 83, 803 834.
49. Salgado-Pineda P., Delaveau P., Blin O. Nieoullon A. (2005) Dopaminergic contribution to the regulation of emotional perception. Clin. Neuropharmacol. 28, 228 237.
50. Seeman P. Van Tol H. H. (1994) Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15, 264 270.
51. Smith Y. Paré D. (1994) Intra-amygdaloid projections of the lateral nucleus in the cat: PHA-L anterograde labeling combined with postembedding GABA and glutamate immunocytochemistry. J. Comp. Neurol. 342, 232 248.
52. Snyder G. L., Fienberg A. A., Huganir R. L. Greengard P. (1998) A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-Regulated phosphoprotein (Mr 32ákDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J. Neurosci. 18, 10297 10303.
53. Stocca G. Vicini S. (1998) Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J. Physiol. 507, 13 24.
54. Surmeier D. J., Bargas J., Hemmings Jr. H. C., Nairn A. C. Greengard P. (1995) Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 14, 385 397.
55. Thomson A. M. (2000) Facilitation, augmentation and potentiation at central synapses. Trends Neurosci. 23, 305 312.
56. Turner B. H. Herkenham M. (1991) Thalamoamygdaloid projections in the rat: a test of the amygdala's role in sensory processing. J. Comp. Neurol. 313, 295 325.
57. Walker D. L. Davis M. (2002) The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol. Biochem. Behav. 71, 379 392.
58. Yu W. Miller R. F. (1995) NBQX, an improved non-NMDA antagonist studied in retinal ganglion cells. Brain Res. 692, 190 194.
59. Zinebi F., Xie J., Liu J., Russell R. T., Gallagher J. P., McKernan M. G. Shinnick-Gallagher P. (2003) NMDA currents and receptor protein are downregulated in the amygdala during maintenance of fear memory. J. Neurosci. 23, 10283 10291.